Abstract
The addition of inhaled budesonide to usual care is safe and may reduce the risk of disease progression in patients hospitalised because of COVID-19 pneumonia https://bit.ly/3tEQo3p
Trial registration: ClinicalTrials.gov NCT04355637 .
All Keywords
【초록키워드】 COVID-19, Pneumonia, risk, Disease progression, Patient, Safe, usual care, inhaled budesonide, hospitalised, addition, reduce, 【제목키워드】 Treatment, clinical trial, randomised, inhaled budesonide, hospitalised patient,
【초록키워드】 COVID-19, Pneumonia, risk, Disease progression, Patient, Safe, usual care, inhaled budesonide, hospitalised, addition, reduce, 【제목키워드】 Treatment, clinical trial, randomised, inhaled budesonide, hospitalised patient,